Rahul Dalal MD MPH (He/Him)

Inflammatory Bowel Disease

Gastroenterologist at Brigham and Women's Hospital

Summary

Dr. Rahul Dalal is a gastroenterologist in Boston, MA and is affiliated with Brigham and Women's Hospital. He received his medical degree from The Warren Alpert Medical School of Brown University and has been in practice 2 years. He also speaks multiple languages, including Spanish. He specializes in inflammatory bowel disease and is experienced in general internal medicine and gastroenterology.

Harvard TH Chan School of Public HealthMPH, Clinical Effectivenesss, 2020 - 2022
Mass General Brigham/Brigham and Women's HospitalFellowship, Gastroenterology, 2019 - 2022
University of PennsylvaniaCertificate, Healthcare Quality Improvement and Patient Safety, 2018 - 2019
University of Pennsylvania Health SystemResidency, Internal Medicine, 2015 - 2018
The Warren Alpert Medical School of Brown UniversityClass of 2015
Yale UniversityBS, Molecular Biophysics and Biochemistry, Magna Cum Laude, 2007 - 2011

AOA Inductee Alpha Omega Alpha Honor Medical Society
T32 DK007533 NIH, 2020
Fellows-in-Training Award (IBD) American College of Gastroenterology, 2020
Associate Member Sigma Xi Scientific Research Honor Society, 2015
Summer Intern Scholarship Recipient American Association of Thoracic Surgery, 2013
T35 HL094308 NIH, 2012
Henry Edwards Ellsworth Prize in Science Yale University, 2011
Distinction in Molecular Biophysics and Biochemistry Yale University, 2011
Richter Research Fellowship Yale University, 2008
Join now to see all

PubMed

Books/Book Chapters

Inflammatory Bowel Disease
Chapter: Tricks of the Trade: Treating Your Patient with Moderate to Severe IBD
Page 147 - 182Dalal RS, Klapproth JM, Lichtenstein GREditors: Cohen R.Humana Press2017
First Aid for the USMLE Step 1 2014
Chapter: Microbiology
Page 119 - 194Dalal REditors: Le T, Bhushan V, Sochat M, Micevic G, Petersen M.The McGraw Hill Companies, New York2014

Lectures

Predictors of ustekinumab failure after dose intensification among patients with Crohn’s disease
American College of Gastroenterology Annual Scientific Meeting (Virtual) - 10/26/2020
Pre-admission cannabis use is positively correlated with inpatient opioid dose exposure in hospitalized patients with inflammatory bowel diseases
North American Conference of Gastroenterology Fellows, American College of Gastroenterology - 3/2020
A multimodal intervention reduces intravenous opioid exposure among hospitalized patients with inflammatory bowel disease
American College of Gastroenterology Annual Scientific Meeting - 10/29/2019
Blood and skeletal muscle biomarkers for neurocognitive decline after cardiopulmonary bypass
Warren Alpert Medical School Summer Showcase, Providence, RI - 2012
Join now to see all

Other

Linking Strain Engraftment in FMT With Maintenance of Remission in Crohn's Disease
Dalal, R
https://www.practiceupdate.com/content/linking-strain-engraftment-in-fmt-with-maintenance-of-remission-in-crohns-disease/112749/12/9/1
Practice Update, Gastroenterology - 2/2/2021
Preparing for Clerkships: Learning to Deliver Specialty-Specific Oral Presentations
Daniel M, Heney R, Kwan B, Mannino C, Williams C, Macdonald K, Williams J, Reardon J, Resnick-Ault D, Schaetzel-Hill T, Cormier J, Schwede M, Sangal R, Dalal R, George..., MedEdPORTAL Publications
https://www.mededportal.org/publication/10261
10/29/2015
First Aid Step 1 Flash Facts 2013, Biochemistry and Renal Sections
Dalal R
https://www.usmle-rx.com/content/step-1-flash-facts
1/1/2013

Rahul S. Dalal, MD, MPH, on the Benefits of Risankizumab Dose Intensification in CDJune 2nd, 2025
Vedolizumab Doesn’t Increase Risk of C Diff in Ulcerative ColitisDecember 28th, 2021
Multimodal Intervention Reduces Opioid Use in Hospitalized Patients with IBDNovember 11th, 2019
Join now to see all